コンテンツへスキップ
Merck

SAB4500112

Sigma-Aldrich

抗C/EBP-β ウサギ宿主抗体

affinity isolated antibody

別名:

AGP/EBP, C/EBP β, C/EBP-related protein 2, CCAAT/enhancer binding protein β, CEBPB

ログイン組織・契約価格を表示する


About This Item

MDL番号:
UNSPSCコード:
12352203
NACRES:
NA.41

由来生物

rabbit

結合体

unconjugated

抗体製品の状態

affinity isolated antibody

抗体製品タイプ

primary antibodies

クローン

polyclonal

形状

buffered aqueous solution

分子量

antigen 36 kDa

化学種の反応性

human, rat, mouse

濃度

~1 mg/mL

テクニック

ELISA: 1:10000
immunohistochemistry: 1:50-1:100
western blot: 1:500-1:1000

NCBIアクセッション番号

UniProtアクセッション番号

輸送温度

wet ice

保管温度

−20°C

ターゲットの翻訳後修飾

unmodified

遺伝子情報

human ... CEBPB(1051)

詳細

Anti-C/EBP-β Antibody detects endogenous levels of total C/EBP-β protein.
CCAAT/enhancer-binding protein-β (C/EBP-β) is encoded by the gene mapped to human chromosome 20q13.13. The encoded protein belongs to the C/EBP family. C/EBP-β is a leucine-zipper transcription factor and is highly expressed during the early stages of adipocyte development. Alternative splicing of C/EBP-β leads to the formation of three isoforms such as, C/EBPβ-1 with 346 amino acids, C/EBPβ-2 with 323 amino acid and C/EBPβ with 146 amino acids.

免疫原

The antiserum was produced against synthesized peptide derived from human C/EBP-beta.

Immunogen Range: 201-250

生物化学的/生理学的作用

CCAAT/enhancer-binding proteins (C/EBPs) regulate expression of various cytokines and chemokines such as, interleukin-6 (IL-6), IL-8 and monocyte chemoattractant protein-1 (MCP-1). C/EBP-β plays a vital role in the regulation of gluconeogenesis and adipogenesis gene expression. The encoded protein also modulates the gene expression of human immunodeficiency virus-1 (HIV-1) and other retroviruses (human T-cell leukemia virus type (HTLV-) and simian immunodeficiency viruses (SIV)). This is carried out by regulating various process, like C-C chemokine receptor type 5 (CCR5) expression, virus promoter activities, cytokine and chemokine production and virus protein function. C/EBPβ is involved in various cellular processes such as metabolism, development and differentiation. Overexpression of C/EBP-β mRNA has been observed in various types of cancers.

特徴および利点

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

物理的形状

ウサギIgGのPBS溶液(Mg2+およびCa2+を含まず)、pH 7.4、150 mM NaCl、0.02% アジ化ナトリウム、50% グリセロール

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our 製品選択ツール.

保管分類コード

10 - Combustible liquids

WGK

nwg

引火点(°F)

Not applicable

引火点(℃)

Not applicable


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection
Liu Y, et al.
Future Microbiology, 4, 299-321 (2009)
Genomic imbalances in Schistosoma-associated and non-Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis.
Armengol G
Cancer Genetics and Cytogenetics, 177, 16-19 (2007)
C/EBP?-1 promotes transformation and chemoresistance in Ewing sarcoma cells
Gardiner JD, et al.
Oncotarget, 8, 26013-26026 (2017)
Dan Liu et al.
Nature communications, 9(1), 1739-1739 (2018-05-02)
Chemoresistance is a major unmet clinical obstacle in ovarian cancer treatment. Epigenetics plays a pivotal role in regulating the malignant phenotype, and has the potential in developing therapeutically valuable targets that improve the dismal outcome of this disease. Here we
Keito Okazaki et al.
Nature communications, 11(1), 5911-5911 (2020-11-22)
Transcriptional dysregulation, which can be caused by genetic and epigenetic alterations, is a fundamental feature of many cancers. A key cytoprotective transcriptional activator, NRF2, is often aberrantly activated in non-small cell lung cancers (NSCLCs) and supports both aggressive tumorigenesis and

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)